Authors: Harris, LN Liotcheva, V Broadwater, G Ramirez, MJ Maimonis, P Anderson, S Everett, T Harpole, D Moore, MB Berry, DA Rizzeri, D Vredenburgh, JJ Bentley, RC

Citation: Ln. Harris et al., Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy, J CL ONCOL, 19(6), 2001, pp. 1698-1706

Authors: Treon, SP Maimonis, P Bua, D Young, G Raje, N Mollick, J Chauhan, D Tai, YT Hideshima, T Shima, Y Hilgers, J von Mensdorff-Pouilly, S Belch, AR Pilarski, LM Anderson, KC

Citation: Sp. Treon et al., Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma, BLOOD, 96(9), 2000, pp. 3147-3153

Authors: Cheung, TH Wong, YF Chung, TKH Maimonis, P Chang, AMZ

Citation: Th. Cheung et al., Clinical use of sevum c-erbB-2 in patients with ovarian masses, GYNECOL OBS, 48(2), 1999, pp. 133-137